Delivery Order SPE2DB20D3103-SPE2DB25FP7L5
- Not listed
- The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,419.41 by the Defense Logistics Agency (DLA) to provide EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of January 26, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $6,432 delivery order to Amerisourcebergen Drug Corporation for EXFORGE 10-160 MG tablets. Under this firm fixed price contract, Amerisourcebergen will deliver 30 tablets of EXFORGE, an antihypertensive medication, from its facility in Conshohocken, Pennsylvania to an unknown customer by July 19, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will perform the order without the use of major subcontractors. As a component of the U.S....
- The U.S. government has awarded a firm fixed price delivery order valued at $3,716.11 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of EXFORGE 5-160 MG TABLET 30S. This order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, has received numerous federal contracts...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order, valued at $3,721.70, is for the supply of 4565296476 - EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance through July 31, 2024 and uses a Firm Fixed Price pricing type. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,166.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 5-160 MG TABLET 30S pharmaceuticals. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order valued at approximately $3,487 to Amerisourcebergen Drug Corporation for 4561409523 EXFORGE 5-320 MG TABLET 30S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 5-6, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at one thousand eight hundred thirty-three dollars and thirty-one cents ($1,833.31) by the Defense Logistics Agency (DLA) to supply EXFORGE 10-160 MG tablets. As the prime contractor, Amerisourcebergen will deliver thirty tablets to the DLA location in Conshohocken, Pennsylvania by November 16, 2023. This delivery order was issued against an existing indefinite-delivery contract held by Amerisourcebergen with...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,827 to Amerisourcebergen Drug Corporation for the supply of 4561308467 EXFORGE 5-320 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products from its place of performance in Conshohocken, Pennsylvania by June 21, 2023 in support of the Defense Logistics Agency's medical supply chain requirements. No major...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7L5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,826.35 to AmerisourceBergen Drug Corp for EXFORGE 5-160 MG tablets (30-count supply) on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The EXFORGE delivery represents the company's ongoing role as a prime vendor within DLA's pharmaceutical supply chain, fulfilling individual medication orders for federal healthcare programs. This contract reflects the routine transactional activity typical of DLA's medical supply operations, whereby orders are issued against the larger indefinite delivery vehicle to provide specific pharmaceutical commodities as needed by Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/5/25 |